Results 11 to 20 of about 6,465,161 (268)

Progression-free survival and overall survival of the cohort.

, 2022
Progression-free survival and overall survival of the cohort.
Chun-Fu Lin (12174572), Yee Chao (804364), Muh-Lii Liang (11204487), Keng-Li Lan (1459669), Tai-Tong Wong (48446), Feng-Chi Chang (435054), Yu-Mei Kang (12174569), Yi-Yen Lee (271429), Shih-Chieh Lin (63678), Hsin-Hung Chen (789932), Sanford P. C. Hsu (3177300), Yi-Wei Chen (48440)   +11 more
core   +1 more source

Progression-free survival analysis based on whether a complete response was attained.

, 2021
Progression-free survival analysis based on whether a complete response was attained.
Elvina Almuradova (11663234), Merve Guner Oytun (11663231), Mustafa Harman (11663237), Ruchan Uslu (816262), Gulcan Bulut (11663228), Bulent Karabulut (11663240)   +5 more
core   +2 more sources

Progression-free survival according to MTV.

, 2022
Progression-free survival according to MTV.
Nina Jehanno (11949663), Pierre Payoux (3484706), Daniel Orbach (11949669), Marie-Pierre Castex (11949666), Thomas Mognetti (582844), Corradini Nadège (11949672), Helio Fayolle (11949660), Anne Hitzel (11949675), Valerie Lauwers-Cances (437048)   +8 more
core   +1 more source

Exploring the relationship between Overall Survival (OS), Progression Free Survival (PFS) and Objective Response Rate (ORR) in patients with advanced melanoma

Cancer Treatment and Research Communications, 2021
Purpose: From 2011 to 2016, 13 randomized clinical trials with active controls were submitted to U.S. Food and Drug Administration (FDA) for the treatment of advanced melanoma.
Manasi Sheth, Jinnie Ko
doaj   +1 more source

Progression-free survival and overall survival of adult and pediatric patients with intracranial germinoma.

, 2022
Progression-free survival and overall survival of adult and pediatric patients with intracranial germinoma.
Chun-Fu Lin (12174572), Yee Chao (804364), Muh-Lii Liang (11204487), Keng-Li Lan (1459669), Tai-Tong Wong (48446), Feng-Chi Chang (435054), Yu-Mei Kang (12174569), Yi-Yen Lee (271429), Shih-Chieh Lin (63678), Hsin-Hung Chen (789932), Sanford P. C. Hsu (3177300), Yi-Wei Chen (48440)   +11 more
core   +1 more source

The impact of LncRNA dysregulation on clinicopathology and survival of pancreatic cancer: a systematic review and meta-analysis (PRISMA compliant)

Cancer Cell International, 2021
Purpose An increasing number of studies have reported a significant association between long non-coding RNAs (lncRNAs) dysregulation and pancreatic cancers.
Elahe Seyed Hosseini, Ali Nikkhah, Amir Sotudeh, Marziyeh Alizadeh Zarei, Fatemeh Izadpanah, Hossein Nikzad, Hamed Haddad Kashani   +6 more
doaj   +1 more source

Prognostic significance of sarcopenia diagnosed based on the anthropometric equation for progression-free survival and overall survival in patients with colorectal cancer

Frontiers in Nutrition, 2023
BackgroundThe purpose of this study was to investigate the prognostic significance of sarcopenia diagnosed based on anthropometric equations for progression-free survival (PFS) and overall survival (OS) in patients with colorectal cancer (CRC).MethodsA ...
Hailun Xie, Hailun Xie, Lishuang Wei, Shunhui Gao, Shunhui Gao, Mingxiang Liu, Mingxiang Liu, Yanren Liang, Yanren Liang, Guanghui Yuan, Guanghui Yuan, Qiwen Wang, Qiwen Wang, Yansong Xu, Shuangyi Tang, Jialiang Gan, Jialiang Gan   +16 more
doaj   +1 more source

Overall survival and progression-free survival.

, 2022
Overall survival and progression-free survival.
Leana Terblanche (13132388), Matthys H. Botha (10739361)   +1 more
core   +1 more source

Long Non-Coding RNAs ASB16-AS1 and AFAP1-AS1: Diagnostic, Prognostic Impact and Survival Analysis in Colorectal Cancer

The Application of Clinical Genetics, 2022
Naglaa S Elabd,1 Shimaa E Soliman,2 Moamena S Elhamouly,1 Suzy F Gohar,3 Ayman Elgamal,4 Mahmoud Magdy Alabassy,5 Haitham A Soliman,5 Abdelnaser A Gadallah,6 Osama D Elbahr,7 Ghada Soliman,3 Amany A Saleh2 1Tropical Medicine Department, Faculty of ...
Elabd NS, Soliman SE, Elhamouly MS, Gohar SF, Elgamal A, Alabassy MM, Soliman HA, Gadallah AA, Elbahr OD, Soliman G, Saleh AA   +10 more
doaj  

Progression-free survival analysis.

, 2019
Progression-free survival analysis.
Donglin Zhu (231422), Rongming Shen (7041791), Yong Yang (63842), Hongya Xie (529445), Guangda Yuan (7041788), Tengteng Wei (7041785)   +5 more
core   +1 more source